Takeda Pharmaceuticals’ $1.2 Billion License Agreement with Degron Therapeutics

Leila Ahmed
Tagged:

Ropes & Gray advised Takeda Pharmaceuticals on the deal.Takeda Pharmaceuticals announced it has entered into a collaboration and exclusive license agreement with Degron Therapeutics (“Degron”) to…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now